Mucosal Atomization Devices Market - Delivering a Revolutionary Solution to Intranasal Drug Administration
Pharmaceutical Manufacturers Aligning Product Innovation Strategies with the Trend of ‘Needleless’ Drug Administration Systems
- 2019-08-29
- REP-GB-7101
- 48 Tables
- 129 Figures
- 200 pages
-
Press Release:
Mucosal Atomization Devices Market Competition Analysis
Mucosal Atomization Device – Leveraging the Thriving Market Prospects of Non-invasive Treatments
Technological advances have played an active role in transforming numerous key industrial sectors. The healthcare sector has significantly benefitted from the onset of reliable, efficient, cost-effective, and novel drug delivery technologies for several years and mucosal atomization devices (MAD) presents a prime example of the same.
In recent years, mucosal atomization devices have emerged as an ideal alternative for the delivery of drugs via the nasal route owing to multiple key factors. The growing adoption of mucosal atomization devices is primarily attributed to factors such as, non-invasive nature, faster delivery of medication to the bloodstream, ease of administration, and no first-pass metabolism among others. In addition, the surge in the number of chronic diseases such as rhinosinusitis is also expected to increase the adoption of mucosal atomization devices especially worldwide.
Further, emerging nasal delivery systems driven by R&D and technological advances are poised to assist drug manufacturers to produce effective medication using approved products
Mucosal Atomization Devices Market - Key Research Findings
- The global mucosal atomization devices market size in 2018 was ~US$ 400 Mn.
- The mucosal atomization devices market is expected to grow at a CAGR of ~7% during the forecast period 2019-2029.
- Besides the increasing prevalence of sinusitis, there are many other factors, such as increasing healthcare awareness among people, advancements in the healthcare industry, and increasing healthcare expenditure, which are driving the growth of mucosal atomization devices market.
- Collectively, Europe and North America are expected to account for more than half of the revenue share in the mucosal atomization devices industry by the end of 2029.
- North America, due to the strong presence of hospitals and well-established healthcare infrastructure, will continue to be a prominent regional market for mucosal atomization device manufacturers.
- Gas propelled mucosal atomization is a common technology adopted by most of the companies, manufacturing mucosal atomization devices.
Key Factors Shaping the Mucosal Atomization Devices Market
Improved Devices with Technological Advancements in the Healthcare Field
Technological advancements in the field of healthcare are leading to the introduction of new and advanced mucosal atomization devices, which is one of the major factors, responsible for the significant growth of the market.
Nasal mucosal atomization devices are one of the technologically advanced devices that work on the latest techniques. Hence, these are adopted by many pharmaceutical companies. Mucosal atomization devices have improved usability as well as bioavailability data, which is a prominent driver for the growth of the mucosal atomization devices market.
Hence, technological advancements in the field of healthcare are leading to the introduction of new and advanced mucosal atomization devices, which is one of the major factors boosting the growth of the mucosal atomization devices market.
Increasing Adoption of Mucosal Atomization Devices
A larger number of people are shifting towards the use of mucosal atomization devices for efficient drug delivery. Also, most of the pharmaceutical companies are now packaged with a spray applicator rather than a dropper, which is expected to increase the adoption of mucosal atomization devices at a higher rate.
Mucosal atomization devices deliver safe, painless, and rapidly effective treatment for various chronic diseases. Increasing healthcare awareness among people is leading to growth in demand for mucosal atomization devices, especially in developed regions, which is another important factor boosting the growth of the mucosal atomization devices market.
Increasing Prevalence of Sinusitis Expected to Increase Market Demand
Increasing prevalence of chronic diseases such as chronic rhino sinusitis, is one of the important factors propelling the growth of the mucosal atomization devices market. The overall prevalence of chronic rhino sinusitis in the U.S. is 16%, which is expected to increase the usage of mucosal atomization devices.
The diagnosis rate of sinusitis is also high, which will further be a positive aspect for the market. Apart from these factors, there can many other factors, which can be responsible for the significant growth of the mucosal atomization devices market. Increasing collaborations between different companies, increasing per capita income in various emerging regions, etc., can increase the overall growth of the mucosal atomization devices market.
Mucosal Atomization Devices Market Structure Analysis
- The global mucosal atomization devices market represents a limited number of key players. Key players in the mucosal atomization devices market maintain their strategic focus on the development of new and technologically advanced products.
- The mucosal atomization devices market has been relatively moderate in size, which remains a key factor for its dynamic competitive nature.
- Leading manufacturers of mucosal atomization devices are currently prioritizing new product launches, which can be responsible for the significant growth of the mucosal atomization market in regions such as North America, Europe, and China.
- Collaborations and acquisitions have been identified to remain crucial developmental strategies adopted by manufacturers.
- There are various applications of electrical atomizer, which can overcome the obstructions of gas propelled mucosal atomization devices, and can show a significant growth in the forecast years
- Deeper understanding of the market trends is likely to create a bottleneck for prominent players, looking forward to untapped opportunities in the mucosal atomization devices market.
Intranasal Drug Delivery – Away from Needles
In the current scenario, although needle-based injections are the most common route of injectable drug delivery and administration of vaccines, the trend is witnessing a rapid change. The shortcomings of needle-based injections along with fear among patients has led to the onset of novel needleless intranasal drug delivery technologies such as mucosal atomization devices for delivery of intranasal corticosteroids and other drugs.
For instance, a significant number of patients do not opt for needle-based treatments owing to the pain and discomfort caused by needles. Thus, the failure to provide optimum treatment to a large population prompted drug manufacturers to innovate and develop other alternatives. The advantages of advanced intranasal vaccine delivery technologies over the existing treatments has created lucrative opportunities for drug manufacturers. Further, as emerging intranasal delivery technologies eliminate the use of needles, there is no risk of needle-stick problems. Besides, other advantages include, reduced fear among patients, painless drug delivery, and ease of disposal.
From the manufacturer’s point of view, sterile delivery issues are eliminated. Thus, market players operating in the drug industry are focusing on developing reliable, safe, auto-disposable nasal vaccine delivery systems. The logistic benefits coupled with safety features of mucosal atomization devices have created several opportunities for manufacturers especially in the developing regions where the demand is steadily growing.
North America and Europe Remain Lucrative with Efficient Medical Infrastructure
The demand for mucosal atomization devices is expected to surge in North America and Europe in the coming years owing to the presence of large number of hospitals and efficient healthcare infrastructure. Further, medical technology in the developed regions of North America and Europe has made tremendous progress in the last decade which has resulted in the advent of innovative and effective medical solutions for an array of medical problems. In addition, prominent market players are prioritizing product launches owing to the growing demand for novel intranasal drug delivery systems. Further, manufacturers have identified mergers and acquisitions as an effective strategy to penetrate the lucrative markets in untapped regions.
* This data is only a representation. Actual data may vary and will be available in report.
-
2014
-
2018
-
2022
-
2029
Structured WHO Guidelines for Manufactures
Manufacturers operating in the mucosal atomization market have to comply with the nasal vaccine delivery guidelines laid down by the WHO. According to the WHO guidelines for drug administration, the route of delivery must consist a single-use delivery system that is auto-disposal after use. Auto-disposal offers efficient infection control and reduces the risk of cross contamination by a considerable margin. Thus, the WHO and other regulatory agencies insist medical device manufacturers to comply with the laid down guidelines.
Owing to the WHO guidelines for the production of new-age medical devices, manufacturers have established a growing need to innovate their products to suffice the growing global demand.
High demand projected for nasal atomization device
Steady surge in demand slated for fiber optic atomization device
Adoption of gas propelled atomization devices on the rise
Sluggish growth expected for electrical atomization devices
Hospitals to remain the major end user
Gradual increase in demand from ambulatory surgical centers
How Growth will Unfold
Leading manufacturers operating in the mucosal atomization device market are focused on developing products that meet consumer demands and the current regulatory guidelines. At present, consumer awareness regarding mucosal atomization devices in the developing regions is comparatively lower than the developed regions such as North America and Europe. Thus, established manufacturers have pinned their hopes on mergers and acquisitions to penetrate the market in nations such as India and China.
The growing prevalence of chronic diseases such as sinusitis, surge in demand for needleless intranasal drug delivery, increasing consumer awareness over health and wellness, and ongoing R&D activities are likely to provide an impetus to the growth of the global mucosal atomization market.
* This data is only a representation. Actual data may vary and will be available in report.
Click Here To Know How The Growth Will UnfoldCustom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
Overview
Mucosal atomization Devices Market Assessment 2019 - 2029
A recent market study published by FMI on the mucosal atomization devices market includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historic as well as current growth parameters of the mucosal atomization devices market, the growth prospects of the market are obtained with maximum precision.
Mucosal Atomization Devices Market Taxonomy
The global mucosal atomization devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
By Product Type
- Nasal Atomization Devices
- Fibre-Optic Atomization Devices
- Laryngo-Tracheal Atomization Devices
- Bottle Atomizer Devices
By Technology
- Gas Propelled Atomization Devices
- Electrical Atomization Devices
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
What's Included
The report initiates with the executive summary of the mucosal atomization devices market, which includes a summary of key findings and statistics of the market. It also includes the demand & supply-side trends pertaining to the mucosal atomization devices market.
Readers can find the definition and a detailed taxonomy of the mucosal atomization devices market in this chapter, which will help them understand the basic information about the mucosal atomization devices market. Along with this, comprehensive information pertaining to mucosal atomization devices and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the mucosal atomization devices market report.
The mucosal atomization devices market report provides the key market trends that are expected to significantly impact the market growth during the forecast period. Detailed industry trends are provided in this section.
This section includes the factors that have emerged as key successful factors and the strategies adopted by key market participants.
This section explains the global market value analysis and forecast for the mucosal atomization devices market between the forecast periods of 2019-2029.This chapter includes a detailed analysis of the historical mucosal atomization devices market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029). Along with this, pricing analysis of the mucosal atomization devices market at the regional level has been provided in this section. This section also explains the global market volume analysis and forecast for the mucosal atomization devices market between the forecast periods of 2019-2029.
This chapter explains the key macro-economic factors that are expected to influence the growth of the mucosal atomization devices market over the forecast period. Along with the macroeconomic factors, this section also highlights the forecast factors for the mucosal atomization devices market. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
Based on the type, the mucosal atomization devices market is segmented into nasal atomization devices, fibre-optic atomization devices, laryngo-tracheal atomization devices, and bottle atomizer devices.
In this chapter, readers can find information about the key trends and developments in the mucosal atomization devices market and market attractiveness analysis based on the type.
This chapter provides details about the mucosal atomization devices market based on the technology, and has been classified into gas propelled atomization devices and electrical atomization devices. In this chapter, readers can understand the market attractive analysis based on the technology.
This chapter provides details about the mucosal atomization devices market based on the end user, and has been classified into hospitals, ambulatory surgical centers, specialized clinics. In this chapter, readers can understand the market attractive analysis based on the end user
This chapter explains how the mucosal atomization devices market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA).
This chapter includes a detailed analysis of the growth of the North America mucosal atomization devices market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the technology and countries in North America.
This chapter provides the growth scenario of the mucosal atomization devices market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
Important growth prospects of the mucosal atomization devices market based on its end users in several countries such as Germany, the U.K., France, Spain, Italy, Russia, BENELUX, and the Rest of Europe are included in this chapter.
In this chapter, India and ASEAN countries are the prominent countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia mucosal atomization devices market. Readers can find detailed information about the growth parameters of the South Asia mucosal atomization devices market during the forecast period of 2019-2029.
This chapter highlights the growth of the mucosal atomization devices market in East Asia by focusing on China, Japan, and South Korea. This section also help readers understand the key factors that are responsible for the growth of the mucosal atomization devices market in East Asia.
This chapter highlights the growth of the mucosal atomization devices market in Oceania by focusing on Australia and New Zealand. This section also help readers understand the key factors that are responsible for the growth of the mucosal atomization devices market in Oceania.
This chapter provides information about how the mucosal atomization devices market will grow in major countries in the MEA region such as GCC Countries, South Africa, Turkey, and the Rest of MEA, during the forecast period of 2019-2029.
This section highlights the growth prospects of the mucosal atomization devices market for emerging markets such as China, India, and Brazil.
In this chapter, readers can find detailed information about the tier analysis and market concentration of key players in the mucosal atomization devices market, along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the mucosal atomization devices market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Teleflex Incorporated, DeVilbiss Healthcare LLC, Cook Medical Incorporated and Medica Holdings, LLC
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the mucosal atomization devices market report.
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the mucosal atomization devices market.
How the research was conducted?
Primary Research
- C - Level Executives
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Procurement Heads
- Sales Executives
- Distributors
- Traders
- Raw Material Suppliers
- Industry Experts
- End Users
- Current market dynamics and challenges
- Yesteryear trends
- Market characteristics
- Market performance and growth quadrants
- Competition structure and market structure
- Strategic growth initiatives
- Near-term and long-term market growth prospects
- Market segment splits and authenticity
- Opinions on market projections and validity of assumptions
Secondary Research
- Industry Publications
- National Institute of Biomedical Imaging and Bioengineering
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
- Trade Websites
Primary Interview Splits
Mucosal Atomization Devices Market Reports - Table of Contents
23. Assumptions and Acronyms Used
24. Research Methodology
To Learn More About our Comprehensive Perspective on Mucosal Atomization Devices Market,
Get in touch
Harish Tiwari
Global Head - Business Development
Pranay Mhaisekar
Client Partner - Global Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.